Brain Opioid Peptide Changes Track With the Development of High Blood Pressure in Rats
Spontaneously hypertensive rats showed distinct age-related changes in brain opioid peptides linked to blood pressure regions, and antihypertensive drugs partially reversed these changes.
Quick Facts
What This Study Found
SHR rats had distinct age-dependent opioid peptide profiles in brain regions linked to blood pressure control. Antihypertensive drugs partially normalized these changes.
Key Numbers
How They Did This
Opioid peptide concentrations measured by radioimmunoassay in brain regions and pituitary of SHR, WKY, and SD rats at ages 4, 8, 12, 16, and 20 weeks. Effects of antihypertensive drugs and DOCA-salt hypertension also examined.
Why This Research Matters
This connects brain opioid peptide changes to hypertension development. If opioid abnormalities contribute to high blood pressure, they could be targets for new treatments.
The Bigger Picture
High blood pressure affects over a billion people worldwide. If brain opioid peptide abnormalities contribute to hypertension — not just correlate with it — they could represent an entirely new class of drug targets for blood pressure control.
What This Study Doesn't Tell Us
Animal study in a genetic hypertension model. SHR rats are highly inbred and may not represent human essential hypertension. Correlation does not prove causation.
Questions This Raises
- ?Do opioid peptide changes cause or result from hypertension?
- ?Could opioid-modulating drugs be developed specifically for blood pressure management?
Trust & Context
- Key Stat:
- 3 time points, 3 strains Opioid peptides tracked at 4, 8, and 16 weeks across hypertensive and normal rat strains to correlate with hypertension onset
- Evidence Grade:
- Preliminary — animal study using a genetic hypertension model. Shows correlations and drug responses but cannot prove opioid changes cause hypertension.
- Study Age:
- Published in 1992 (34 years ago). The neuroendocrine aspects of hypertension remain an active research area.
- Original Title:
- Age-related changes in opioid peptide concentrations in brain and pituitary of spontaneously hypertensive rats. Effect of antihypertensive drugs and comparison with deoxycorticosterone acetate and salt hypertension.
- Published In:
- Pharmacology, 44(5), 245-56 (1992)
- Authors:
- Li, S J, Wong, S C(2), Hong, J S(5), Ingenito, A J
- Database ID:
- RPEP-00241
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How could opioid peptides affect blood pressure?
The brain has opioid receptors in regions that control blood pressure. If the balance of opioid peptides in these areas shifts, it could alter how the brain regulates heart rate, blood vessel tone, and overall blood pressure.
Could this lead to new blood pressure treatments?
Potentially. If correcting opioid peptide imbalances helps normalize blood pressure — as the partial reversal by existing drugs suggests — then drugs specifically targeting brain opioid systems could become a new approach for hard-to-treat hypertension.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00241APA
Li, S J; Wong, S C; Hong, J S; Ingenito, A J. (1992). Age-related changes in opioid peptide concentrations in brain and pituitary of spontaneously hypertensive rats. Effect of antihypertensive drugs and comparison with deoxycorticosterone acetate and salt hypertension.. Pharmacology, 44(5), 245-56.
MLA
Li, S J, et al. "Age-related changes in opioid peptide concentrations in brain and pituitary of spontaneously hypertensive rats. Effect of antihypertensive drugs and comparison with deoxycorticosterone acetate and salt hypertension.." Pharmacology, 1992.
RethinkPeptides
RethinkPeptides Research Database. "Age-related changes in opioid peptide concentrations in brai..." RPEP-00241. Retrieved from https://rethinkpeptides.com/research/li-1992-agerelated-changes-in-opioid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.